Amgen acquires Bergamo.

Amgen acquires Bergamo, expands procedures in Brazil Amgen , the world’s largest biotechnology firm, announced today the growth of its functions in Brazil, including the acquisition of Bergamo, a privately-held Brazilian pharmaceutical organization. Amgen in addition has agreed to reacquire rights in Brazil to its items which were previously granted to Mantecorp . Together, these transactions provides Amgen a significant existence in Brazil and instant, direct access to 1 of the fastest developing pharmaceutical marketplaces in the world. Bergamo is a leading supplier of medicines to the hospital sector in Brazil with features in oncology medicines and has manufacturing services in Sao Paulo condition.